Warning: implode(): Invalid arguments passed in /www/htdocs/w00d8752/html/includes/inc_partner.php on line 443

Institution statistics - SAFETY

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - France 

Ranking results:

Past rankings:
Subject specific rankings are not yet available..
Ranking timeline:

European project participation (2000-01-01 - 2017-12-31 SAFETY):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 56
As coordinator: 5
As participant: 48
Sole participant: 3
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2008 0 10.265.427 968.394 3
2005 0 6.999.837 279.993 1
2004 0 26.880.014 1.252.987 3
2003 0 2.255.786 250.643 1
2002 1.643.791 35.287.242 4.036.648 1 20
2001 4.649.901 15.532.424 3.330.218 4 8
2000 1.716.642 35.845.932 2.857.424 3 12
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE151
KAROLINSKA INSTITUTE124
UNIVERSITY COLLEGE LONDON108
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD78
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE72
KING'S COLLEGE LONDON64
MEDICAL RESEARCH COUNCIL64
INSERM TRANSFERT60
KATHOLIEKE UNIVERSITEIT LEUVEN59
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE56
CHARITE UNIVERSITAETSMEDIZIN BERLIN51
EUROPEAN MOLECULAR BIOLOGY LABORATORY44
INSTITUT PASTEUR44
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM43
STICHTING KATHOLIEKE UNIVERSITEIT43
UPPSALA UNIVERSITET43
LEIDEN UNIVERSITY MEDICAL CENTER40
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT39
UNIVERSITY OF COPENHAGEN39
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS38
COMMISSARIAT A L'ENERGIE ATOMIQUE38
ISTITUTO SUPERIORE DI SANITA37
MEDIZINISCHE UNIVERSITAET WIEN36
THE UNIVERSITY OF EDINBURGH36
UNIVERSITY OF HELSINKI35
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN34
LUNDS UNIVERSITET34
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV33
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR32
THE UNIVERSITY OF MANCHESTER32
UNIVERSITAETSKLINIKUM HEIDELBERG32
UNIVERSITY OF GLASGOW32
UNIVERSITY OF NEWCASTLE UPON TYNE31
CONSIGLIO NAZIONALE DELLE RICERCHE29
UNIVERSITAETSKLINIKUM FREIBURG29
UNIVERSITE DE GENEVE29
EBERHARD KARLS UNIVERSITAET TUEBINGEN28
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS27
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE27
MEDIZINISCHE HOCHSCHULE HANNOVER27
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM25
UNIVERSITE LIBRE DE BRUXELLES25
DEUTSCHES KREBSFORSCHUNGSZENTRUM24
UNIVERSITA DEGLI STUDI DI MILANO24
UNIVERSITA DEGLI STUDI DI PADOVA23
UNIVERSITAET ZUERICH23
UNIVERSITE CATHOLIQUE DE LOUVAIN23
UNIVERSITAIR MEDISCH CENTRUM UTRECHT22
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI22
WEIZMANN INSTITUTE OF SCIENCE22
INSTITUTO DE SALUD CARLOS III21
MAXPLANCKGESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV21
UNIVERSITY OF BIRMINGHAM21
UNIVERSITY OF DUNDEE21
UNIVERSITY OF WALES CARDIFF21
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH20
GENOME RESEARCH20
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS20
ACADEMISCH ZIEKENHUIS GRONINGEN19
UNIVERSITAET ULM19
UNIVERSITE DE LIEGE19
UNIVERSITY OF LEICESTER19
GOETEBORGS UNIVERSITET18
HEINRICHHEINEUNIVERSITAET DUESSELDORF18
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI18
LEIDEN UNIVERSITY18
RUPRECHT KARLS UNIVERSITAET HEIDELBERG18
THE UNIVERSITY OF SHEFFIELD18
UNIVERSITEIT MAASTRICHT18
UNIVERSITY OF LEEDS18
VRIJE UNIVERSITEIT BRUSSEL18
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS17
SERVICIO MADRILENO DE SALUD17
TEL AVIV UNIVERSITY17
THE UNIVERSITY OF LIVERPOOL17
UNIVERSITY OF BRISTOL17
UNIVERSITY OF OSLO17
UNIVERSITY OF SOUTHAMPTON17
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM16
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER16
REGION HOVEDSTADEN16
TECHNISCHE UNIVERSITAET DRESDEN16
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA16
UNIVERSITAETSKLINIKUM BONN16
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS16
UNIVERSITEIT GENT16
UNIVERSITY OF BERGEN16
ACADEMISCH ZIEKENHUIS LEIDEN15
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE15
JOHANNES GUTENBERG UNIVERSITAET MAINZ15
LUND UNIVERSITY15
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON15
TARTU ULIKOOL15
THE HEBREW UNIVERSITY OF JERUSALEM15
UNIVERSITA DEGLI STUDI DI TORINO15
UNIVERSITAET BERN15
UNIVERSITE CLAUDE BERNARD LYON 115
UNIVERSITEIT UTRECHT15
UNIVERSITY OF CRETE15
UNIVERSITY OF ZURICH15
Constancy:

Total number of partners:9690

Partner loyalty:
Frequent Partner: (> 2 projects): 6267
Rare Partner: 3423

Frequent / Rare Partner Ratio: 1.83

Diversity:

Subjects: Diversity index:0.19
Categories:
Category:No:
BIOLOGICAL SCIENCES575
RTD HORIZONTAL TOPICS389
SOCIAL AND ECONOMIC CONCERNS221
PROTECTING MAN AND HIS ENVIRON93
INDUSTRY AND TECHNOLOGY60
AGRICULTURE AND MARINE RESOURC20
ENERGY6
MEASUREMENTS AND STANDARDS3
PHYSICAL AND EXACT SCIENCES1

Project overview:

Start dateProjectacronymrolefundingpartners
2008-01-01Detecting and Eliminating Bacteria UsinG Information Technologies DebugITparticipant6.414.91514
2008-01-01Guard, Anticipation and Prediction. A new approach to Health Risk Prediction GAPparticipant930.70710
2008-01-01Evolving Platform for Improving Living Expectation of Patients Suffering from IctAl Events EPILEPSIAEparticipant2.919.8057
2005-04-01Safe production and use of nanomaterials NANOSAFE2participant6.999.83725
2004-02-01Global allergy and asthma european network GA²LENparticipant1433
2004-02-01Chemicals as contaminants in the food chain: an NOE for research, risk assessment and education CASCADEparticipant14.400.00021
2004-02-01Diet, genomics and the metabolic syndrome: an integrated nutrition, agro-food, social and economic analysis LIPGENparticipant12.480.00022
2003-01-01Quantification of coeliac disease toxic gluten in foodstuffs using a chip system with integrated extraction, fluidics and biosensoric detection step 2 of exploratory award exaw-1999-01542 CD-CHEFparticipant2.255.7869
2002-12-01Multidisciplinary approach to airborne pollutant health related issues : modelization with combustion engine exhausts MAAPHRIcoordinator1.643.7917
2002-12-01Endocrine disrupters : exploring novel endpoints, exposure, low-dose-and mixture-effects in humans, aquatic wildlife and laboratory animals EDENparticipant8.605.52922
2002-11-01Genetic analysis of the chloroquine drug resistance and accelerated-resistance-to-multiple-drugs phenotype in the human malarial parasite plasmodium falciparum MALCROSSparticipant749.4495
2002-11-01Risk of thyroid cancer following exposure to I-131 early in life CHILD-THYRparticipant161.0467
2002-10-01Identification, presentation and delivery of epitopes for development of novel vaccine for cytomegalovirus infections EPI-PEP-VACparticipant1.904.4199
2002-10-01Priming protective mhc class i-restricted t cell immunity by novel vaccine delivery strategies that target alternative epitope repertoires CTLATVAXparticipant1.150.0004
2002-10-01Evaluation of a therapeutic vaccination strategy for hiv infection (THERAVAC) THERAVACparticipant2.379.6479
2002-09-01Virological characterisation of primary hiv infection in the concerted action on seroconversion to aids and death in europe (CASCADE VIROLOGY) CASCADE VIROLOGYparticipant528.24014
2002-09-01Unraveling hcv pathogenicity for the preclinical development of new therapeutic strategies (HEPCVAX) HEPCVAXparticipant3.355.50716
2002-09-01Hiv-1 reverse transcriptase inhibitor and its consequences for viral virulence VIRULENCEparticipant1.299.9988
2002-09-01Analysis of the molecular mechanisms of hepatitis C virus (HCV) resistance to antiviral therapy HEPAC-RESISTparticipant1.498.02810
2002-09-01Experimental and clinical dissection of innate immunity against intracellular pathogens INNATE DEFENSEparticipant1.370.0205
2002-09-01Design of novel inhibitors of hcv rna helicase - potential antivirals for treatment and protection against hepatitis c virus-induced diseases (HCV INHIBITORS) HCV INHIBITORSparticipant986.9976
2002-09-01Structure, function and vaccine potential of the vir multigene family in malaria VIRIMALparticipant1.196.1806
2002-05-01Iron in hemochromatosis : deleterious effects of an essential nutrient NUTRIENT IRON TOXICIparticipant2.065.6877
2002-01-01Molecular analysis and mechanistic elucidation of the functionality of probiotics and prebiotics in the inhibition of pathogenic microorganisms to combat gastrointestinal disorders and to improve human health PROPATHparticipant1.310.6007
2002-01-01The role of chemokines in the pathogenesis of atopic eczema CHEMOKINES-ATOPYparticipant1.749.9245
2002-01-01Alcohol related cancers and genetic susceptibility in europe ARCAGEparticipant2.085.72715
2002-01-01Phase-i and ii trials of the malaria pre-erythrocytic vaccine lsa-3 and refinement of measurable outcomes (EMLI) EMLIparticipant1.462.7339
2002-01-01Potential adverse effects of gsm cellular phones on hearing GUARDparticipant835.85810
2002-01-01Enhanced laboratory surveillance of measles ELSMparticipant591.65310
2001-12-01Development of prophylactic and therapeutic vaccines optimised for cellular processing and presentation to t lymphocytes and targeted to professional antigen presenting cells (protarvac) PROTARVACcoordinator1.249.2714
2001-12-01Rational approaches towards understanding and overcoming hiv protease inhibitor resistance (HIV PR INHIBITORS) HIV PR INHIBITORSparticipant1.616.3128
2001-12-01Small carrier peptides as a new tool for selective drug delivery (PEPTIDES IN DRUG DELIVERY) PEPTIDES IN DRUG DELparticipant1.463.3377
2001-11-01European vaccine effort against hiv/aids - ii EUROVAC-IIparticipant2.999.99713
2001-10-01Cross-presentation of hiv and lipopeptide vaccines by dendritic cells. CONCEPCION MARANON Lcoordinator125.6001
2001-09-01Emerging variants of hepatitis b virus: new tools for epidemiological survey, diagnosis of infection, and monitoring of drug resistance (HEPBVAR) HEPBVARcoordinator1.565.0305
2001-09-01Type iv secretion systems as targets for anti-infectious therapies (TFSS) TFSSparticipant1.642.8816
2001-09-01Immunological memory and vaccination (MEMOVAX) MEMOVAXparticipant1.299.0226
2001-03-01Nutrient-gene interactions in human obesity: implications for dietary guidelines NUGENOBparticipant3.208.84011
2001-03-01Risk assessment of wood dust: assessment of exposure, health effects and biological mechanisms WOOD-RISKparticipant1.350.0004
2001-03-01Early malnutrition and programming of adult degenerative diseases: experimental, epidemiological and preventive studies NUTRIXparticipant1.952.0355
2001-01-01Identification of critical rat testicular genes altered after fetal androgenic disruption by flutamide: use of dna microarray approach ENDISRUPTcoordinator1.710.0004
2000-11-01Human transmissible spongiform encephalopathies: the neuropathology network participant400.00065
2000-10-01Creutzfeldt-jakob disease: epidemiology, risk factors and diagnostic tests. participant386.00011
2000-10-01Human pneumocystis carinii infection in immunocompetent hosts : a public health issue in europe EUROCARINIIparticipant800.00010
2000-09-15Genetic polymorphism of goat milk proteins: incidence on allergenicity BEVILACQUA CLAUDIAcoordinator125.6001
2000-09-01European resistance intervention study - reducing resistance in respiratory tract pathogens in children EURISparticipant1.717.4597
2000-04-01Mechanisms of renal na/k/ci cotransporter bsc1 hyperactivity in dahl salt-sensitive rats. LOUBONAFONTEJOSEMANUcoordinator125.6001
2000-03-01Hepatitis c virus (hcv) : prevention and treatment of infection and disease HCVACCparticipant4.098.03015
2000-03-01European prospective study of environment, allergy and the lung (preferred name - European community respiratory health survey II) EU-PEALparticipant2.400.00020
2000-02-01Mucosal immunization - cluster project MUCIMMparticipant2.999.84011

overview shows latest 50 from 56 projects (2000-01-01 - 2017-12-31)
A full list of projects can be found here:

Alias institution names:
  • INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
  • INSTITUT NATIONAL DE LA RECHERCHE MEDICALE
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALA
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSERM
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE UNITE DE RECHERCHE 515 HOPITAL SAINTANTOINE
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICINALE
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MIDICALE
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCSE MEDICALE
  • INSTITUT NATIONAL DE LA SANTE ET LA RECHERCHE MEDICALE
  • INSTITUT NATIONAL DE LA SANTE ET RECHERCHE MEDICALE
  • INSTITUT NATIONAL DE SANTE ET FECHERCHE MEDICALE
  • INSTITUT NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE
  • INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE ADR PARIS XI
  • LNSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: